Pharma News

Bionomics Limited, a clinical-stage biopharmaceutical company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the BNC210 development prog...

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alc...

Krystal Biotech has released positive phase 3 results for its gene therapy Vyjuvek (beremagene geperpavec) developed to treat dystrophic epidermolysis bullosa (EB), an inherited connective tissue d...

Alembic Pharmaceuticals has received FDA approval of its abbreviated new drug application (ANDA) for formoterol fumarate inhalation solution, 20 mcg/2 ml per unit-dose vial, a generic of Mylan Special...

TRACON Pharmaceuticals (NASDAQ:TCON) Inc reported that its partners had announced that envafolimab (KN035) had received marketing authorization from the Chinese National Medical Products Administratio...

Pfizer Inc. Report shares extended gains Monday after the drugmaker said it's preparing to boost production of its Covid antiviral treatment to combat the potential impact of the newly-discovered O...

South Africa's health minister says there is "absolutely no need to panic" over the new coronavirus variant Omicron, despite a surge in cases.

The FDA has granted fast track designation to the investigational immunotherapy agent, BNT111 (FixVac), for the treatment of patients with advanced melanoma, according to a press release issued by...

Pfizer Inc has sued a longtime employee for allegedly stealing "scores" of confidential documents, including some related to its COVID-19 vaccine, as she prepared to jump to a competitor. ...

The FDA has granted a fast track designation to arfolitixorin as a potential therapeutic option for patients with metastatic colorectal cancer (mCRC), according to an announcement from Isofol Medical ...

Transplant patients who experience a potentially deadly viral infection that doesn’t respond to existing treatments have a new FDA-approved treatment option.

Aadi Bioscience's new cancer med Fyarro boasts two firsts: It's the California-based company's first commercial product, and it's the first treatment to take aim at an ultrarare and aggressive form...